ATLAS MEDICAL PRACTICE — All Prescriptions & Medications
Practice Code: N83023 | ST. HELENS, WA9 1LN
Over the last 12 months, ATLAS MEDICAL PRACTICE prescribed 351,308 items across 653 different medications at a total cost of £2,549,227 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Olsalazine sodium | 10 | 532 | £724 | -0.4% vs avg |
| Ciclesonide | 10 | 11 | £354 | -32.1% ▼ |
| Cefradine | 10 | 1,120 | £764 | +5.6% ▲ |
| Estradiol valerate | 10 | 560 | £47 | -48.8% ▼ |
| Ready to serve 2.4 kcal/ml milkshake higher volume (0913011) | 10 | 118.5K | £721 | -50.6% ▼ |
| Ready to serve infant formula, high energy (0913104) | 10 | 139.8K | £2.1K | -9.5% ▼ |
| Other eye tear/lubricant/astringent preparations | 10 | 1,900 | £143 | -8.6% ▼ |
| 10 | 165 | £603 | +12.4% ▲ | |
| 10 | 200 | £260 | -60.6% ▼ | |
| 10 | 1,300 | £41 | -22.5% ▼ | |
| 10 | 26 | £178 | -45.7% ▼ | |
| 10 | 605 | £1.0K | -52.8% ▼ | |
| 10 | 260 | £69 | -61.6% ▼ | |
| 10 | 850 | £156 | -61.2% ▼ | |
| 10 | 100 | £699 | -21.1% ▼ | |
| Chlortalidone | 11 | 165 | £301 | +11.5% ▲ |
| Colestyramine | 11 | 646 | £148 | -61.8% ▼ |
| Acarbose | 11 | 924 | £254 | -5.8% ▼ |
| Indoramin | 11 | 616 | £487 | -27.6% ▼ |
| Calcitriol | 11 | 952 | £202 | -29.5% ▼ |
| Ciprofloxacin | 11 | 55 | £49 | +38.4% ▲ |
| Olopatadine | 11 | 55 | £52 | -74.9% ▼ |
| Aluminium chloride | 11 | 680 | £52 | +35.7% ▲ |
| 11 | 105 | £143 | +98.8% ▲ | |
| 11 | 190 | £306 | +74.9% ▲ | |
| 11 | 1,104 | £29 | -78.0% ▼ | |
| 11 | 120 | £331 | -77.0% ▼ | |
| Mebeverine hydrochloride compound preparations | 12 | 720 | £627 | +6.1% ▲ |
| Balsalazide sodium | 12 | 1,344 | £300 | -19.4% ▼ |
| Budesonide | 12 | 356 | £792 | -23.4% ▼ |
| Pericyazine | 12 | 1,008 | £402 | -89.1% ▼ |
| Trifluoperazine | 12 | 3,600 | £1.9K | -20.4% ▼ |
| Hyoscine | 12 | 64 | £413 | +72.9% ▲ |
| Domperidone | 12 | 573 | £13 | -66.4% ▼ |
| Aspirin | 12 | 301 | £8 | +22.1% ▲ |
| Rufinamide | 12 | 672 | £1.1K | -30.1% ▼ |
| Repaglinide | 12 | 2,016 | £180 | -50.4% ▼ |
| Cyclopentolate hydrochloride | 12 | 135 | £119 | +109.8% ▲ |
| Travoprost | 12 | 60 | £38 | -74.5% ▼ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 12 | 1,302 | £141 | +38.3% ▲ |
| 12 | 140 | £391 | -23.5% ▼ | |
| 12 | 1,800 | £2.4K | +44.6% ▲ | |
| 12 | 15 | £263 | +76.4% ▲ | |
| Eprosartan | 13 | 364 | £177 | -35.6% ▼ |
| Cilostazol | 13 | 728 | £410 | -6.3% ▼ |
| Oxazepam | 13 | 130 | £13 | -39.0% ▼ |
| Levomepromazine maleate | 13 | 1,092 | £286 | +41.6% ▲ |
| Eslicarbazepine acetate | 13 | 364 | £1.6K | -41.7% ▼ |
| Erythromycin | 13 | 484 | £193 | -62.5% ▼ |
| Metformin hydrochloride/pioglitazone | 13 | 728 | £443 | +2.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.